Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SLO-BID

THEOPHYLLINE

Standard Dose
125MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview SLO-BID is listed in Drugs@FDA under application 089540 (ANDA).

Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 125MG Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 1998-12-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview SLO-BID is listed in Drugs@FDA under application 089540 (ANDA). Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 125MG Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 1998-12-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
SLO-BID (THEOPHYLLINE) | Drug Monograph | MedicHelpline